- New
Lost Mary Maryliq - Red Apple Ice, 20mg
81692
CHF6.90
Tax included
Lost Mary Maryliq - Red Apple Ice offers the sweet, fruity taste of ripe red apples combined with a refreshingly cool note. The juicy apple gives the liquid a natural sweetness with a slightly tart nuance reminiscent of freshly picked apples. The icy freshness provides an invigorating note that makes the vaping experience particularly refreshing. This harmonious blend of fruity sweetness and pleasant coolness is perfect for those who want to enjoy a classic apple flavour with a refreshing twist.
Sale from 18 years.
Please note the safety instructions at the bottom of the page!
Maryliq by Lost Mary is a nicotine salt liquid that was created in conjunction with ELFBAR.
Lost Mary Maryliq is the liquid version of the popular Lost Mary e-cigarettes.
This product is known for its high-quality e-liquids.
With a PG/VG ratio of 50/50, it offers a perfect balance between propylene glycol (PG) and vegetable glycerine (VG), which ensures optimal vapour production and pleasant flavour.
The 10ml bottle is compact and easy to carry, so you can take your favourite e-liquid with you wherever you go.
This product contains nicotine salts, which are absorbed more quickly by the body and provide a stronger nicotine effect.
Safety WarningSignal word
DANGER |
|||
 |
|
||
4 other products in the same category:
Lost Mary Maryliq - Red Apple Ice offers the sweet, fruity taste of ripe red apples combined with a refreshingly cool note. The juicy apple gives the liquid a natural sweetness with a slightly tart nuance reminiscent of freshly picked apples. The icy freshness provides an invigorating note that makes the vaping experience particularly refreshing. This harmonious blend of fruity sweetness and pleasant coolness is perfect for those who want to enjoy a classic apple flavour with a refreshing twist.
Sale from 18 years.
Please note the safety instructions at the bottom of the page!
@CUSTOMER_NAME@
@AUTHOR_PROFILE@ @COMMENT_ISO_COUNTRY@@COMMENT_TITLE@
@COMMENT_COMMENT@